Latvija - latviešu - Zāļu valsts aģentūra

accord healthcare b.v., netherlands - fulvestrants - Šķīdums injekcijām pilnšļircē - 250 mg

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - ozanimod hidrohlorīds - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imūnsupresanti - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

accord healthcare s.l.u. - trastuzumab - breast neoplasms; stomach neoplasms - antineoplastiski līdzekļi - breast cancermetastatic breast cancer zercepac is indicated for the treatment of adult patients with her2 positive metastatic breast cancer (mbc):as monotherapy for the treatment of those patients who have received at least two chemotherapy regimens for their metastatic disease. pirms ķīmijterapijas ir jāietver vismaz anthracycline un taxane, ja vien pacientiem ir derīgi šiem apstrādes veidiem. hormonu receptoru pozitīvu pacientiem jābūt arī neizdevās hormonu terapiju, ja vien pacientiem ir derīgi šiem apstrādes veidiem.                      in combination with paclitaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease and for whom an anthracycline is not suitable. kopā ar docetaxel par attieksmi pret pacientiem, kuri nav saņēmuši ķīmijterapiju to metastātiska slimība. kombinācijā ar aromatāzes inhibitoru, lai ārstētu menopauzes pacientiem ar hormonu receptoru pozitīvu mbc, kas agrāk nav ārstēti ar trastuzumab. early breast cancer zercepac is indicated for the treatment of adult patients with her2 positive early breast cancer (ebc). pēc operācijas, ķīmijterapija (neoadjuvant vai palīgvielas) un staru terapijas laikā (ja piemērojams). šādas palīgvielas ķīmijterapija ar doksorubicīna un ciklofosfamīdu, kopā ar paclitaxel vai docetaxel. kopā ar palīgvielu ķīmijterapiju, kas sastāv no docetaxel un carboplatin. in combination with neoadjuvant chemotherapy followed by adjuvant zercepac therapy, for locally advanced (including inflammatory) disease or tumours > 2 cm in diameter. zercepac should only be used in patients with metastatic or early breast cancer whose tumours have either her2 overexpression or her2 gene amplification as determined by an accurate and validated assay. metastatic gastric cancer zercepac in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of adult patients with her2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction who have not received prior anti-cancer treatment for their metastatic disease. zercepac should only be used in patients with metastatic gastric cancer (mgc) whose tumours have her2 overexpression as defined by ihc2+ and a confirmatory sish or fish result, or by an ihc 3+ result. precīza un apstiprinātas pārbaudes metodes vajadzētu izmantot,.

Latvija - latviešu - Zāļu valsts aģentūra

csl behring gmbh, germany - albumīns, cilvēka - Šķīdums infūzijām - 200 g/l

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

aimmune therapeutics ireland limited - defatted powder of arachis hypogaea l., semen (peanuts) - peanut hypersensitivity - allergens - palforzia is indicated for the treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. palforzia may be continued in patients 18 years of age and older. palforzia should be used in conjunction with a peanut-avoidant diet.

Latvija - latviešu - Zāļu valsts aģentūra

zentiva, k.s., czech republic - bisoprolola fumarāts - tablete - 1,25 mg

Latvija - latviešu - Zāļu valsts aģentūra

zentiva, k.s., czech republic - bisoprolola fumarāts - tablete - 5 mg

Latvija - latviešu - Zāļu valsts aģentūra

zentiva, k.s., czech republic - bisoprolola fumarāts - tablete - 10 mg

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

ražots es pēc sia "pharm&med"pasūtījuma, dzelzavas iela 120z, rīga - cits, suspensija eļļā

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

topformula healthcare ab - kapsula